Avidity Biosciences, Inc. (RNAM)
Feb 27, 2026 - RNAM was delisted (reason: acquired by NVS)
71.36
0.00 (0.00%)
Inactive · Last trade price on Feb 26, 2026

Avidity Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
-10,8683,4706711,4741,115
Upgrade
Market Cap Growth
-213.25%417.36%-54.52%32.27%16.40%
Upgrade
Enterprise Value
-9,0421,8891391,080703
Upgrade
Last Close Price
-70.6928.508.8721.7523.29
Upgrade
PS Ratio
-579.49318.3970.15159.85119.53
Upgrade
PB Ratio
-6.442.441.342.552.92
Upgrade
P/TBV Ratio
-6.442.441.342.552.92
Upgrade
EV/Sales Ratio
-482.13173.3114.50117.1175.35
Upgrade
Debt / Equity Ratio
0.030.030.010.020.020.03
Upgrade
Net Debt / Equity Ratio
-0.98-0.98-1.05-1.17-1.04-1.03
Upgrade
Net Debt / EBITDA Ratio
2.222.223.972.513.383.35
Upgrade
Net Debt / FCF Ratio
2.482.484.854.754.314.00
Upgrade
Asset Turnover
0.010.010.010.020.020.02
Upgrade
Quick Ratio
8.758.7515.427.4911.8413.70
Upgrade
Current Ratio
9.209.2015.747.5812.0013.86
Upgrade
Return on Equity (ROE)
-43.98%-43.98%-33.47%-39.34%-36.27%-34.32%
Upgrade
Return on Assets (ROA)
-26.47%-26.47%-21.60%-23.24%-20.97%-19.38%
Upgrade
Return on Capital Employed (ROCE)
-42.30%-42.30%-25.90%-43.00%-30.50%-29.70%
Upgrade
Earnings Yield
--6.30%-9.29%-31.65%-11.80%-10.59%
Upgrade
FCF Yield
--6.11%-8.88%-18.39%-9.43%-8.84%
Upgrade
Buyback Yield / Dilution
-23.42%-23.42%-52.83%-39.97%-25.91%-91.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.